For instance, Anti-MDA5 antibodies are associated with skin lesions and interstitial lung disease, while anti-TIF1-γ antibodies are linked to cancer-associated dermatomyositis, anti-Mi-2 antibodies, in turn, correlate with immune disorders driven skin diseases (12, 13). This evidence concerns the gene TRIM33 and dermatomyositis.